FIELD: medicine.
SUBSTANCE: offered group of inventions aims at drug delivery and includes lachrymonasal system compositions and structures. Offered are a medicinal insert containing a coating and a medicated core. The medicinal insert is enclosed in an implant to be inserted into a patient's eye or adjacently. A medicated core comprises a therapeutically active substance contained in a matrix. Exposure of the active substance matrix to the lachrymal fluid provides effective prolonged release of the therapeutic active substance into the lachrymal fluid. In specific embodiments, the active substance matrix contains a non-bioabsorbable polymer, e.g. silicone, in an inhomogeneous mixture with the active substance. Also, there are offered a method for making the medicinal insert and implant configured for inserting into the patient's eye or adjacently, containing a passage adapted for receiving the medicinal insert or medicated core. Besides, the group of inventions involves the method of active substance delivery to the patient's eye, as well as the method of treating the patient's eye with using said implant containing the medicinal insert or medicated core.
EFFECT: enabled higher clinical effectiveness in the requiring patients due to target-specific prolonged drug delivery.
20 cl, 2 tbl, 10 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
IMPLANTS OF NASOLACRIMAL DRAINAGE SYSTEM FOR DRUG THERAPY | 2007 |
|
RU2414199C2 |
INTRAOCULAR SYSTEMS OF SUSTAINED-RELEASE DRUG DELIVERY AND METHOD OF TREATING OPHTHALMIC DISEASES | 2010 |
|
RU2532333C2 |
METHOD OF TREATING ELEVATED INTRAOCULAR PRESSURE USING INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEM | 2014 |
|
RU2664686C2 |
INTRACHAMBER IMPLANTS WITH PROLONGED RELEASE OF THERAPEUTIC AGENT | 2011 |
|
RU2565445C2 |
DRUG CORES FOR DELAYED RELEASE OF THERAPEUTIC MEANS | 2008 |
|
RU2478366C2 |
REDUCTION OF INTRAOCULAR PRESSURE BY INTRACHAMBER BIMATOPROST IMPLANTS | 2011 |
|
RU2586298C2 |
OPHTHALMIC SYSTEM FOR SUSTAINED RELEASE OF DRUG TO EYE | 2013 |
|
RU2652063C2 |
INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
LACHRYMAL OPENING INSERTS AND METHOD FOR THERAPEUTIC AGENT DELIVERY | 2008 |
|
RU2459646C2 |
INTRAOCULAR IMPLANTS CONTAINING PROSTAMIDE AND METHODS OF THEIR USE | 2014 |
|
RU2650614C2 |
Authors
Dates
2011-03-10—Published
2007-04-02—Filed